Sinotau Pharmaceutical Group, a leading enterprise in targeted radionuclide theranostics, recently announced completion for a new round of financing over RMB1.1\u00a0billion.<\/p>\n
This round of financing was invested by many national organizations, industry groups and well-known investment institutions, including SDIC Venture Capital, Goldstone, China Structural Reform Fund, Genertec Venture Capital, CITIC Securities, etc. China Life Private Equity and Lotus Lake Ventures continue to increase their shareholdings.
\n\u00a0
\nThe funds raised in this round will be used for the research, development and clinical application of diagnostic and therapeutic radiopharmaceuticals to bring health benefits to Chinese patients. The successful completion of this round of financing fully reflects the high recognition of Sinotau’s innovative strength and market value by capital and industry.
\n\u00a0
\nSinotau is an innovative pharmaceutical company\u00a0specializing in the R&D, production, clinical application and academic promotion of radiopharmaceuticals. Headquartered in Beijing,\u00a0Sinotau\u00a0has\u00a0modern radiopharmaceutical R&D centers and production sites\u00a0in Shanghai, Jiangsu, Guangdong and Sichuan, and has a branch office in the US,\u00a0partnering with more than a dozen or so\u00a0multinational pharmaceutical companies.
\n\u00a0
\nRelying on the world’s leading R&D resources of radiopharmaceutical\u00a0precision diagnosis and therapies, Sinotau has taken the lead in a number of radiopharmaceuticals\u00a0for\u00a0targeted therapies\u00a0and precise\u00a0diagnostics in the fields of oncology, neurology and cardiology, and has accumulated rich experience in radiopharmaceutical R&D, clinical trials, registration and filing, production and marketing\u00a0in China. It is expected that within this year, its A\u03b2-PET imaging agent for Alzheimer’s disease diagnosis will be approved and marketed in China, which, together with various targeted therapeutic drugs, will provide patients with integrated solutions for precise diagnosis and treatment, helping patients to achieve early diagnosis and treatment, and a lifetime without or delayed onset of disease.<\/p>\n","protected":false},"excerpt":{"rendered":"
Sinotau Pharmaceutical Group, a leading enterprise in targeted radionuclide theranostics, recently announced completion for a new round of financing over RMB1.1\u00a0billion. This round of financing was invested by many national organizations, industry groups and well-known investment institutions, including SDIC Venture Capital, Goldstone, China Structural Reform Fund, Genertec Venture Capital, CITIC Securities, etc. China Life Private […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[11],"tags":[],"class_list":["post-3868","post","type-post","status-publish","format-standard","hentry","category-company-news"],"meta_box":[],"_links":{"self":[{"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/posts\/3868","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/comments?post=3868"}],"version-history":[{"count":1,"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/posts\/3868\/revisions"}],"predecessor-version":[{"id":3869,"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/posts\/3868\/revisions\/3869"}],"wp:attachment":[{"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/media?parent=3868"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/categories?post=3868"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/tags?post=3868"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}